Abstract
Background
We sought to determine the relationship between 99mTc-sestamibi washout and myocardial properties in hypertrophic cardiomyopathy (HCM) patients.
Methods and Results
Twenty-four HCM patients underwent biventricular cardiac catheterization, with a micromanometer-tipped catheter, both at rest and during atrial pacing, echocardiography and myocardial 99mTc-sestamibi scintigraphy at rest. The 99mTc-sestamibi washout rate (WR) was calculated using initial and delayed planar images. The HCM patients were divided into two groups as follows: Group A consisted of 13 patients showing 99mTc-sestamibi WR < 22.5%; group B of 11 patients showing 99mTc-sestamibi WR ≥ 22.5%. Significant correlations were observed between 99mTc-sestamibi WR and percentage changes in pressure half-time (T 1/2), as well as those in the maximum first derivative LV pressure (LV dP/dt max) (r = .43, P = .033; r = −.63, P = .001). The percentage changes in LV dP/dt max and those in T 1/2 were significantly more reduced in group B than in group A (P < .05). The biphasic force-frequency relation was more frequently observed in group B than in group A (82% vs. 18%).
Conclusion
Increased 99mTc-sestamibi washout is associated with an impaired contractile reserve and prolonged relaxation, suggesting that myocardial 99mTc-sestamibi scintigraphy may be useful in noninvasively detecting the early impairment of myocardial function in HCM patients.
Similar content being viewed by others
References
Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 1979;43:1242-4.
Betocchi S, Bonow RO, Bacharach SL, Rosing DR, Maron BJ, Green MV. Isovolumic relaxation period in hypertrophic cardiomyopathy: Assessment by radionuclide angiography. J Am Coll Cardiol 1986;7:74-81.
Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990;31:1646-53.
Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998;39:266-71.
Morishita S, Kondo Y, Nomura M, Miyajima H, Nada T, Ito S, et al. Impaired retention of technetium-99m tetrofosmin in hypertrophic cardiomyopathy. Am J Cardiol 2001;87:743-7.
Izawa H, Yokota M, Takeichi Y, Inagaki M, Nagata K, Iwase M, et al. Adrenergic control of the force-frequency and relaxation-frequency relations in patients with hypertrophic cardiomyopathy. Circulation 1997;96:2959-68.
Somura F, Izawa H, Iwase M, Takeichi Y, Ishiki R, Nishizawa T, et al. Reduced myocardial sarcoplasmic reticulum Ca2+-ATPase mRNA expression and biphasic force-frequency relations in patients with hypertrophic cardiomyopathy. Circulation 2001;104:658-63.
Isobe S, Izawa H, Takeichi Y, Nonokawa M, Nanasato M, Ando A, et al. Relationship between exercise-induced myocardial ischemia and reduced left ventricular distensibility in patients with nonobstructive hypertrophic cardiomyopathy. J Nucl Med 2003;44:1717-24.
Isobe S, Izawa H, Iwase M, Nanasato M, Nonokawa M, Ando A, et al. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy. J Nucl Med 2005;46:909-16.
Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996;93:841-2.
Henry WL, Clark CE, Epstein SE. Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 1973;47:225-33.
Ohshima S, Isobe S, Izawa H, Nanasato M, Ando A, Yamada A, et al. Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients. J Am Coll Cardiol 2005;46:2061-8.
Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
Takeishi Y, Sukekawa H, Fujiwara S, Ikeno E, Sasaki Y, Tomoike H. Reverse redistribution of technetium-99m-sestamibi following direct PTCA in acute myocardial infarction. J Nucl Med 1996;37:1289-94.
Sugiura T, Takase H, Toriyama T, Goto T, Ueda R, Dohi Y. Usefulness of Tc-99m methoxyisobutylisonitrile scintigraphy for evaluating congestive heart failure. J Nucl Cardiol 2006;13:64-8.
Thet-Thet-Lwin, Takeda T, Wu J, Fumikura Y, Iida K, Kawano S, et al. Enhanced washout of 99mTc-tetrofosmin in hypertrophic cardiomyopathy: Quantitative comparisons with regional 123I-BMIPP uptake and wall thickness determined by MRI. Eur J Nucl Med Mol Imaging 2003;30:966-73.
Hirasaki S, Nakamura T, Kuribayashi T, Shima T, Matsubara K, Azuma A, et al. Abnormal course, abnormal flow, and systolic compression of the septal perforator associated with impaired myocardial perfusion in hypertrophic cardiomyopathy. Am Heart J 1999;137:109-17.
Ohtsuki K, Sugihara H, Kuribayashi T, Nakagawa M. Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. J Nucl Med 1999;40:2007-13.
Takeichi Y, Yokota M, Iwase M, Izawa H, Nishizawa T, Ishiki R, et al. Biphasic changes in left ventricular end-diastolic pressure during dynamic exercise in patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2001;38:335-43.
Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.
Cannon RO III, Schenke WH, Maron BJ, Tracy CM, Leon MB, Brush JE Jr, et al. Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 1987;10:53-62.
Udelson JE, Cannon RO III, Bacharach SL, Rumble TF, Bonow RO. Beta-adrenergic stimulation with isoproterenol enhances left ventricular diastolic performance in hypertrophic cardiomyopathy despite potentiation of myocardial ischemia. Comparison to rapid atrial pacing. Circulation 1989;79:371–82.
Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, Doll HA, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric magnetic resonance imaging. Circulation 2007;115:2418-25.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Isobe, S., Ohshima, S., Unno, K. et al. Relation of 99mTc-sestamibi washout with myocardial properties in patients with hypertrophic cardiomyopathy. J. Nucl. Cardiol. 17, 1082–1090 (2010). https://doi.org/10.1007/s12350-010-9266-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-010-9266-7